bioRxivMicrobiology
A comparison of ThinPrep-PreservCyt against four non-volatile transport media for HPV testing at or near the point of care.
S. G. Badman, A. J. Vallely, C. Pardo, L. P. Mhango, A. M. Cornall, J. Kaldor, D. Whiley
Abstract
IntroductionThe Xpert HPV Test (Cepheid, Sunnyvale, CA) is used at point-of-care for cervical screening in a number of low-and middle-income countries (LMIC). It is validated for use with ThinPrep-PreservCyt (Hologic, Marlborough, MA) transport medium which has a high methanol content and is therefore classified as a dangerous good for shipping; making cost, transportation and use challenging within LMIC. Therefore, we compared the performance of ThinPrep against four non-volatile commercially available media for HPV point-of-care testing. MethodsTen-fold serial dilutions were prepared using three HPV cell lines each positive for 16, 18 or 31 and with each suspended in five different media types. The media types consisted of Phosphate Buffered Saline (Thermo Fischer Scientific, Waltham, MA, USA), Sigma Virocult (Medical Wire & Equipment, Wiltshire, England), MSwab (Copan, Brescia BS, Italy) Xpert Transport Media (Cepheid, Sunnyvale, USA) and ThinPrep-PreservCyt (Hologic Inc., Marlborough, MA). ResultsA total of 105 HPV Xpert tests were conducted in a laboratory setting, with 7 ten-fold dilutions of each of the 3 HPV genotypes tested in all 5 media types. The lowest HPV ten-fold dilution detected for any media, or cell line was the fifth dilution. Mswab was the only media to detect HPV to the 5th dilution across all three cell types. DiscussionMswab transport media may be a suitable alternative to ThinPrep for Xpert HPV point of care testing and increase HPV detection. A field-based, head to head comparison of both media types using the Xpert HPV assay is warranted to confirm these laboratory-based findings.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala
Hong Lou, Eduardo Gharzouzi, … Roberto Orozco·BMC CancerPeer-reviewed·May 15, 2018
- Development and Validation of a Method for Human Papillomavirus Genotyping Based on Molecular Beacon Probes
Jiangfeng Lyu, Yuefeng Yu, … Xuyi Ren·PLoS ONEPeer-reviewed·Nov 29, 2018
- Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota
T. Shibata, M. Nakagawa, … M. S. Robeson·bioRxiv·Jan 27, 2020
- HPV-Associated Tonsillar Intraepithelial Neoplasia and Oral High-Risk HPV mRNA as a Candidate Biomarker
Masashi Mori, Hidenori Tanaka, … Hidenori Inohara·bioRxiv·Oct 19, 2026
- Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR
Caroline Ngetsa, Victor Osoti, … Lynette Isabella Ochola‐Oyier·PLoS ONEPeer-reviewed·Feb 13, 2023
- A new sequencing-based women’s health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis
E. M. Bik, S. W. Bird, … Z. S. Apte·bioRxiv·Nov 13, 2017